NCI raises paylines, commemorates 50th anniversary of the National Cancer Act of 1971

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Pandemic notwithstanding, NCI is on track to reach the 15th percentile for the payline by 2025—a goal set by institute Director Ned Sharpless in response to a deluge of grant applications.

“Congress’s support has allowed NCI to raise the payline for R01 research awards by 35% since 2019. For two consecutive years, we’ve raised grant paylines for [early-stage investigators] as well,” Sharpless said Feb. 11 in his director’s report at a virtual meeting of the National Cancer Advisory Board.

Last year, Sharpless set the goal of reaching the 15th perentile by 2025.

“You can see the [Early Stage Investigator] payline is now 16th percentile. That is the best payline for an R01 out of the NCI in a very long time. And we are also able to sustain continuing awards at 100th percentile.”

To access this subscriber-only content please log in or renew your subscription.

Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.

Login Subscribe
Table of Contents